Bellevue Group’s Agios Pharmaceuticals AGIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$119M Buy
3,590,150
+75,000
+2% +$2.49M 2.63% 11
2025
Q1
$103M Hold
3,515,150
2.31% 12
2024
Q4
$116M Sell
3,515,150
-220,765
-6% -$7.25M 2.22% 13
2024
Q3
$166M Sell
3,735,915
-143,633
-4% -$6.38M 2.69% 12
2024
Q2
$167M Sell
3,879,548
-126,452
-3% -$5.45M 2.72% 12
2024
Q1
$117M Sell
4,006,000
-5,000
-0.1% -$146K 1.79% 17
2023
Q4
$89.3M Sell
4,011,000
-2,500
-0.1% -$55.7K 1.37% 20
2023
Q3
$99.3M Hold
4,013,500
1.6% 17
2023
Q2
$114M Hold
4,013,500
1.62% 17
2023
Q1
$92.2M Sell
4,013,500
-43,292
-1% -$994K 1.34% 18
2022
Q4
$114M Sell
4,056,792
-2,000
-0% -$56.2K 1.51% 18
2022
Q3
$115M Sell
4,058,792
-4,000
-0.1% -$113K 1.65% 15
2022
Q2
$90.1M Sell
4,062,792
-66,500
-2% -$1.47M 1.27% 21
2022
Q1
$120M Sell
4,129,292
-220,000
-5% -$6.4M 1.4% 18
2021
Q4
$143M Buy
4,349,292
+7,300
+0.2% +$240K 1.47% 16
2021
Q3
$200M Sell
4,341,992
-11,000
-0.3% -$508K 2.03% 9
2021
Q2
$240M Sell
4,352,992
-184,100
-4% -$10.1M 2.34% 8
2021
Q1
$234M Buy
4,537,092
+336,090
+8% +$17.4M 2.48% 7
2020
Q4
$182M Buy
4,201,002
+50,000
+1% +$2.17M 2.08% 11
2020
Q3
$145M Buy
4,151,002
+127,429
+3% +$4.46M 2.01% 11
2020
Q2
$215M Buy
4,023,573
+118,129
+3% +$6.32M 3.05% 7
2020
Q1
$139M Sell
3,905,444
-19,510
-0.5% -$692K 2.69% 7
2019
Q4
$187M Buy
3,924,954
+353,400
+10% +$16.9M 2.97% 7
2019
Q3
$116M Buy
3,571,554
+443,420
+14% +$14.4M 2.15% 11
2019
Q2
$156M Buy
+3,128,134
New +$156M 2.66% 10
2018
Q4
Sell
-19,861
Closed -$1.53M 138
2018
Q3
$1.53M Sell
19,861
-8,950
-31% -$690K 0.1% 111
2018
Q2
$2.43M Sell
28,811
-11,489
-29% -$968K 0.21% 82
2018
Q1
$3.3M Sell
40,300
-600
-1% -$49.1K 0.33% 62
2017
Q4
$2.34M Sell
40,900
-4,100
-9% -$234K 0.24% 73
2017
Q3
$3M Hold
45,000
0.31% 67
2017
Q2
$2.32M Hold
45,000
0.27% 76
2017
Q1
$2.63M Hold
45,000
0.35% 69
2016
Q4
$1.88M Hold
45,000
0.38% 65
2016
Q3
$2.38M Buy
45,000
+9,000
+25% +$475K 0.43% 65
2016
Q2
$1.51M Sell
36,000
-18,000
-33% -$754K 0.28% 83
2016
Q1
$2.19M Buy
+54,000
New +$2.19M 0.4% 75